SpyGlass Pharma SGP
NASDAQ SGP
$26.16 +1.56 (+6.34%)
At close: Oct 20, 2026 · 4:00 PM EDT

SpyGlass Pharma (SGP) Enterprise Value (2026)

Updated

SpyGlass Pharma (SGP) posted Enterprise Value of $510.33 million for Q2 2026.

Analysis

SpyGlass Pharma (SGP) Enterprise Value (2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Enterprise Value at SpyGlass Pharma was $744.51 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 SpyGlass Pharma 876.12 Mn 876.12 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 510.33 Mn
API Access

SpyGlass Pharma Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=SGP&period=max&api_key=YOUR_API_KEY